ArticleCancers2026

Pharmacologically Targeting DHODH-Dependent Pyrimidine Metabolism with HSA-Conjugated BRQ Suppresses Leukemogenesis.

Xiaoxu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.